Loading…
Fredun Pharmaceuticals (BSE 539730)₹1,361+0.05%Pharmaceuticals
At the end of the Sep 2026 quarter, Fredun Pharmaceuticals' shareholders were: promoters 44.54%, FIIs 1.07%, DIIs 2.96%, public 51.43%. Promoter holding is unchanged on the quarter. FII holding is up 1.06 percentage points from 0.01% a year earlier. 0.00% of promoter shares were pledged. It had 9,594 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.13% | 49.14% | 49.14% | 48.90% | 48.90% | 48.90% | 48.90% | 48.90% | 43.03% | 44.14% | 44.54% | 44.54% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.46% | 1.07% | 1.07% | 1.07% |
| DIIs | 1.61% | 1.61% | 1.61% | 1.60% | 1.60% | 1.60% | 1.60% | 1.62% | 3.50% | 2.85% | 2.96% | 2.96% |
| Public | 49.26% | 49.25% | 49.25% | 49.50% | 49.50% | 49.50% | 49.50% | 49.47% | 53.01% | 51.94% | 51.43% | 51.43% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 6,834 | 7,504 | 7,508 | 8,015 | 8,118 | 7,973 | 7,903 | 8,117 | 8,762 | 8,335 | 8,900 | 9,594 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Daulat Nariman Medhora | Promoter | 39.41% | 0.00 |
| Nikhil Kishorchandra Vora | Public | 5.42% | New |
| Fredun Nariman Medhora | Promoter | 5.24% | 0.00 |
| Capri Global Ventures Private Limited | Public | 1.44% | New |
| Bank Of India | DII | 1.35% | 0.00 |
| Arun Kumar Mukherjee | Public | 1.23% | New |
| Nav Capital Vcc - Nav Capital Emerging Star Fund | FII | 1.01% | 0.00 |
| Nariman Bamansha Medhora | Promoter | 0.01% | 0.00 |
Promoters held 44.54% of Fredun Pharmaceuticals at the end of the Sep 2026 quarter, down 4.36 percentage points from 48.90% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 1.07% (unchanged at 1.07% a quarter earlier) and domestic institutions (DIIs) held 2.96% (unchanged at 2.96% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Fredun Pharmaceuticals had 9,594 shareholders at the end of the Sep 2026 quarter, against 8,117 a year earlier.
Nikhil Kishorchandra Vora (Public) held 5.42% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.